Surgery Partners, Inc. SGRY
$13.18
-$0.17-1.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -500.00% | 4.77% | 86.18% | 28.39% | 83.87% |
| Total Depreciation and Amortization | -2.48% | 6.06% | 76.70% | -21.31% | 15.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.98% | -8.71% | -64.64% | 13.75% | -29.18% |
| Change in Net Operating Assets | -68.86% | 12.83% | 41.59% | 34.75% | 22.33% |
| Cash from Operations | -27.06% | 95.00% | -7.18% | 28.22% | -1.81% |
| Capital Expenditure | 6.84% | 29.52% | 42.60% | 1.98% | 13.01% |
| Sale of Property, Plant, and Equipment | -99.21% | -- | 227.27% | -- | -- |
| Cash Acquisitions | 102.50% | 90.45% | -25.00% | 82.71% | 98.10% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 118.60% | 146.90% | -155.17% | -678.57% | -19.44% |
| Cash from Investing | -1,042.86% | 82.46% | -12.89% | 6.85% | 100.86% |
| Total Debt Issued | -8.30% | -8.52% | 160.44% | -24.05% | -84.71% |
| Total Debt Repaid | 35.37% | -62.45% | -239.82% | -19.26% | 78.90% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15.26% | 10.30% | -13.71% | -25.31% | 14.41% |
| Cash from Financing | 91.85% | -285.10% | 23.33% | -1,052.05% | -133.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.38% | -43.28% | -23.48% | -662.65% | -26.50% |